Table of ContentsView AllTable of ContentsFunctionsAssociated ConditionsSymptoms of ImbalanceHormones and Neurotransmitters

Table of ContentsView All

View All

Table of Contents

Functions

Associated Conditions

Symptoms of Imbalance

Hormones and Neurotransmitters

Common neurotransmitters includeserotonin,epinephrine,dopamine,acetylcholine, andgamma-aminobutyric acid(GABA).

Predominant Neurotransmitters illustration

Predominant Neurotransmitters and Their Functions

Neurotransmitters are often described as excitatory or inhibitory because they can activate or inhibit specific actions of their target cell.Each neurotransmitter can have various effects on different target cells—some can be inhibitory, and some can be excitatory.

At least 100 neurotransmitters have been identified in the body.A few of these neurotransmitters are particularly well understood in the context of health and disease, and many of their actions can be modified with medication.

Neurotransmitters initiate their action when they bind to a receptor on their target cell. A receptor is a small protein that can attach to a specific chemical or hormone in the body.

Receptors that can bind to neurotransmitters are usually located on the surface of a neuron or a muscle. When a receptor attaches to a neurotransmitter, certain cell functions are initiated or inhibited for a limited time.

Epinephrine and Norepinephrine

These fast-acting neurotransmitters adjust blood pressure, heart rate, breathing, and digestion. Your body’s release and response toepinephrine(also called adrenaline) usually increases during periods of excitement, anxiety, or fear.

Norepinephrine(also called noradrenaline) has effects similar to epinephrine but often works a little slower, and the effects last a little longer.

Acetylcholine

Acetylcholineplays a role in memory and movement. This neurotransmitter is released from motor neurons (nerves that power muscles) before binding to muscle cells to stimulate movement.Interestingly,during the dreaming stage of sleep, muscle movement is inhibited, which prevents you from moving and “acting out” your dreams.

Serotonin

Serotoninworks with other neurotransmitters to mediate mood, sleep, appetite, digestion, immunity, and more.

Dopamine

Dopamineis involved in regulating fluid muscle movement. This neurotransmitter also plays a role in motivation.Addictive behaviors are associated with a craving for dopamine.

Experiences that cause the body to release dopamine include being praised, winning something, or eating something that tastes good.

Serotonin vs. Dopamine: What Are the Differences?

Gamma-Aminobutyric Acid (GABA)

Often described as an inhibitory neurotransmitter,GABAinhibits the activation of certain neurons. This neurotransmitter prevents brain damage and is also involved in relaxation and sleep.Someantiepileptic medicationsmay increase the body’s response to GABA.

DisruptionDisorders associated with neurotransmitter disruption can be due to high or low levels, but some diseases occur with normal neurotransmitter levels and abnormal responsiveness, such as high or low receptor activity.

Disruption

Disorders associated with neurotransmitter disruption can be due to high or low levels, but some diseases occur with normal neurotransmitter levels and abnormal responsiveness, such as high or low receptor activity.

Neurotransmitters and Associated Conditions

Several of the commonly defined neurotransmitters are associated with medical disorders and diseases. Treatment is often focused on balancing the neurotransmitter disruption, which can help alleviate symptoms.

Parkinson’s Disease

Depression

Schizophrenia

Myasthenia Gravis

Serotonin Syndrome

Addiction

Neurotransmitter DysfunctionMany medical and psychiatric conditions involve neurotransmitter dysfunction. Alzheimer’s disease, a type of dementia, is associated with a decline in acetylcholine activity in thehippocampus(an area of the brain that’s involved in memory and emotions).Anxiety disorders,insomnia,andfibromyalgiaare associated with disruptions in serotonin activity.

Neurotransmitter Dysfunction

Many medical and psychiatric conditions involve neurotransmitter dysfunction. Alzheimer’s disease, a type of dementia, is associated with a decline in acetylcholine activity in thehippocampus(an area of the brain that’s involved in memory and emotions).Anxiety disorders,insomnia,andfibromyalgiaare associated with disruptions in serotonin activity.

Symptoms of Neurotransmitter Imbalance

Neurotransmitters regulate, maintain, and adjust your mood, memory, actions, and survival. Temporary or persistent neurotransmitter imbalance can cause a range of effects.

Symptoms of neurotransmitter imbalance include:

Neurotransmitters and hormones are types of chemical messengers. Many of the body’s hormones and neurotransmitters activate or inhibit each other, and they work together in a tightly controlled manner.

Some similarities and differences include:

Neurotransmitters work together with hormones to regulate different functions. For example, epinephrine reduces inflammation, serotonin helps keep your body’s immune system functioning, andcortisol(a hormone) suppresses your immune system.This balance keeps you healthy.

Summary

Neurotransmitters are small molecules that regulate the nervous system. Your body is always balancing neurotransmitter action to help you survive—and any imbalance can cause symptoms or disease. There are many neurotransmitters in the body. Several are associated with illnesses and can be modified with medication to control symptoms.

Sometimes neurotransmitter activity changes quickly and briefly in response to emotions and actions, such as exercise and meditation. This is a completely healthy and normal way that your neurotransmitters adapt to the changes in your body.

11 Sources

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

Rajnák C, Imrich R, Štofko J, Matonok A, Boča R.Molecular properties of monoaminergic catecholamines in water.ACS Omega.2024;9(34):36086-36098. doi:10.1021/acsomega.3c10227

Lou JS, Su M, Wang J, Do HN, Miao Y, Huang XY.Distinct binding conformations of epinephrine with α- and β-adrenergic receptors.Exp Mol Med.2024 Sep 2. doi:10.1038/s12276-024-01296-x

Tsentsevitsky AN, Sibgatullina GV, Odoshivkina YG, et al.Functional and structural changes in diaphragm neuromuscular junctions in early aging.Int J Mol Sci. 2024;25(16):8959. doi:10.3390/ijms25168959

Maheshwarla Saravanan S, Prathap L, Padathpeedika Khalid J, Mary Martin T, Kishore Kumar MS.Serotonin’s role in inflammatory signaling pathway modulation for colon cancer suppression.Cureus.2024;16(8):e66040. doi:10.7759/cureus.66040

Teleanu RI, Niculescu AG, Roza E, Vladâcenco O, Grumezescu AM, Teleanu DM.Neurotransmitters-key factors in neurological and neurodegenerative disorders of the central nervous system.Int J Mol Sci.2022;23(11):5954. doi:10.3390/ijms23115954

Qu S, Yu Z, Zhou Y, et al.Gut microbiota modulates neurotransmitter and gut-brain signaling.Microbiol Res.2024;287:127858. doi:10.1016/j.micres.2024.127858

Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US). Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health [Internet]. Washington (DC): US Department of Health and Human Services; 2016.Chapter 2, the neurobiology of substance use, misuse, and addiction.

Ghasemi M, Navidhamidi M, Rezaei F, Azizikia A, Mehranfard N.Anxiety and hippocampal neuronal activity: relationship and potential mechanisms.Cogn Affect Behav Neurosci. 2022;22(3):431-449. doi:10.3758/s13415-021-00973-y

Blake MJ, Trinder JA, Allen NB.Mechanisms underlying the association between insomnia, anxiety, and depression in adolescence: Implications for behavioral sleep interventions.Clin Psychol Rev. 2018;63:25-40. doi:10.1016/j.cpr.2018.05.006

Walitt B, Urrútia G, Nishishinya MB, Cantrell SE, Häuser W.Selective serotonin reuptake inhibitors for fibromyalgia syndrome.Cochrane Database Syst Rev. 2015;2015(6):CD011735. doi:10.1002/14651858.CD011735

Meet Our Medical Expert Board

Share Feedback

Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit

Was this page helpful?

Thanks for your feedback!

What is your feedback?OtherHelpfulReport an ErrorSubmit

What is your feedback?

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.Cookies SettingsAccept All Cookies

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookies SettingsAccept All Cookies